---
figid: PMC7922220__cells-10-00437-g001
figtitle: GnRH-I receptor signaling in ovarian cancer cells
organisms:
- Mus musculus
- Rattus norvegicus
- Homo sapiens
organisms_ner:
- Mus musculus
- Homo sapiens
- Rattus norvegicus
- Drosophila melanogaster
pmcid: PMC7922220
filename: cells-10-00437-g001.jpg
figlink: pmc/articles/PMC7922220/figure/cells-10-00437-f001/
number: F1
caption: 'Schematic representation of GnRH-I receptor signaling in ovarian cancer
  cells. Binding of GnRH-I and GnRH-I analogs causes G-protein αi-mediated activation
  of a PTP, resulting in dephosphorylated EGF-R and inhibition of EGF-R signaling
  through ERK1/2 or PI3K/AKT pathway leading to reduction of proliferation. GnRH-I-induced
  activation of PTP also inhibits the signal transduction of GPER and membrane-associated
  ERα through transactivation of EGF-R. In addition, GnRH induces activation of NFκB
  to reduce and FAS-ligand to increase apoptosis. Finally, GnRH agonists activate
  the JNK/AP-1 pathway resulting in increased G0/1 phase of the cell cycle and decreased
  synthesis of DNA. Further details are described in the text. Abbreviations: Akt,
  protein kinase B (PKB); AP-1, activator protein-1; E2, estradiol; EGF, epidermal
  growth factor; EGF-R, EGF receptor; ERα, estrogen receptor α; ERK1/2, p44/42 mitogen-activated
  protein (MAP) kinase; FAS, Fas receptor; FasL, Fas ligand; GDP, guanosine diphosphate;
  GnRH, gonadotropin-releasing hormone; GPER, G-protein coupled estrogen receptor;
  GRB2, growth factor receptor-bound protein 2; GTP, guanosine triphosphate; HB-EGF,
  heparin-binding EGF-like growth factor; JNK, c-Jun N-terminal kinase; JunD, transcription
  factor JunD; MEK, mitogen-activated protein kinase kinase (MAP2K); MMP, matrix metalloproteinase;
  NFkB, nucleus factor kB; PI3K, phosphoinositide 3-kinase; PTP, protein tyrosine
  phosphatase; RAS, G-protein rat sarcoma; SOS, guanine nucleotide exchange factor
  “son of sevenless”; SRE, serum response element; Src, tyrosine kinase cellular sarcoma;
  SRF, serum response factor; TAM, tamoxifen.'
papertitle: Role of Gonadotropin-Releasing Hormone (GnRH) in Ovarian Cancer.
reftext: Carsten Gründker, et al. Cells. 2021 Feb;10(2):437.
year: '2021'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9628684
figid_alias: PMC7922220__F1
figtype: Figure
redirect_from: /figures/PMC7922220__F1
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7922220__cells-10-00437-g001.html
  '@type': Dataset
  description: 'Schematic representation of GnRH-I receptor signaling in ovarian cancer
    cells. Binding of GnRH-I and GnRH-I analogs causes G-protein αi-mediated activation
    of a PTP, resulting in dephosphorylated EGF-R and inhibition of EGF-R signaling
    through ERK1/2 or PI3K/AKT pathway leading to reduction of proliferation. GnRH-I-induced
    activation of PTP also inhibits the signal transduction of GPER and membrane-associated
    ERα through transactivation of EGF-R. In addition, GnRH induces activation of
    NFκB to reduce and FAS-ligand to increase apoptosis. Finally, GnRH agonists activate
    the JNK/AP-1 pathway resulting in increased G0/1 phase of the cell cycle and decreased
    synthesis of DNA. Further details are described in the text. Abbreviations: Akt,
    protein kinase B (PKB); AP-1, activator protein-1; E2, estradiol; EGF, epidermal
    growth factor; EGF-R, EGF receptor; ERα, estrogen receptor α; ERK1/2, p44/42 mitogen-activated
    protein (MAP) kinase; FAS, Fas receptor; FasL, Fas ligand; GDP, guanosine diphosphate;
    GnRH, gonadotropin-releasing hormone; GPER, G-protein coupled estrogen receptor;
    GRB2, growth factor receptor-bound protein 2; GTP, guanosine triphosphate; HB-EGF,
    heparin-binding EGF-like growth factor; JNK, c-Jun N-terminal kinase; JunD, transcription
    factor JunD; MEK, mitogen-activated protein kinase kinase (MAP2K); MMP, matrix
    metalloproteinase; NFkB, nucleus factor kB; PI3K, phosphoinositide 3-kinase; PTP,
    protein tyrosine phosphatase; RAS, G-protein rat sarcoma; SOS, guanine nucleotide
    exchange factor “son of sevenless”; SRE, serum response element; Src, tyrosine
    kinase cellular sarcoma; SRF, serum response factor; TAM, tamoxifen.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - hb
  - Gnrh1
  - Egf
  - Egfr
  - Fasl
  - Fas
  - Fasn
  - Gper1
  - Slc25a3
  - Ptpru
  - Ptprs
  - Reg1
  - Reg2
  - Src
  - Grb2
  - Pik3r1
  - ras
  - Hras
  - Kras
  - Rem1
  - Mapk8
  - Esr1
  - Eral1
  - Mdk
  - Akt1
  - Sema6a
  - Mapk3
  - Mapk1
  - Jund
  - Nfkb1
  - Srf
  - Fos
  - Jun
  - GSTM1
  - GNRH1
  - GNRH2
  - EGF
  - EGFR
  - TAM
  - STIM1
  - MMP1
  - MMP2
  - MMP3
  - MMP7
  - MMP8
  - MMP9
  - MMP10
  - MMP11
  - MMP12
  - MMP13
  - MMP14
  - MMP15
  - MMP16
  - MMP17
  - MMP19
  - MMP20
  - MMP21
  - MMP23B
  - MMP24
  - MMP25
  - MMP26
  - MMP27
  - MMP28
  - FASLG
  - FAS
  - FASN
  - GPER1
  - SLC25A3
  - REG1A
  - PTPRU
  - SRC
  - FGR
  - FYN
  - YES1
  - GRB2
  - XYLT2
  - SOS1
  - SOS2
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - KRAS
  - HRAS
  - NRAS
  - MAPK8
  - MAPK9
  - MAPK10
  - ESR1
  - ERAL1
  - MAP2K7
  - MAP2K1
  - MAP2K2
  - AKT1
  - AKT2
  - AKT3
  - SEMA6A
  - MAPK3
  - MAPK1
  - JUND
  - NFKB1
  - RELA
  - RELB
  - REL
  - NFKB2
  - SRF
  - FOS
  - FOSB
  - JUN
  - JUNB
  - Faslg
  - Ptpn1
  - Ptpn13
  - Pik3cg
  - Rela
  - Ccne1
  - PolG1
  - pyd
  - Mmp1
  - Fas1
  - FASN1
  - Fas2
  - Fas3
  - fand
  - tei
  - rg
  - FASN2
  - FASN3
  - Ptp69D
  - Src42A
  - Csk
  - Src64B
  - drk
  - Sos
  - Pi3K21B
  - Pi3K59F
  - Pi3K68D
  - Pi3K92E
  - Ras64B
  - Ras85D
  - bsk
  - era
  - Dsor1
  - Mtk
  - Akt
  - levy
  - COX6AL2
  - rl
  - Dif
  - dl
  - Rel
  - mal
  - bs
  - kay
  - AP-1gamma
  - Jra
  - CycE
  - cyc
  - TAM
  - GDP
---
